Kula da mataki na kawar da thrombus

Thrombectomy tiyata hanya ce da zata iya cire thrombus da sauri cikin kankanin lokaci.Bayan an kawar da thrombus, toshewar jijiyar da aka katange za ta dawo da hankali, kuma za a iya samun kyakkyawan hangen nesa na dogon lokaci ta hanyar kawar da thrombus gaba daya ta hanyar tiyata.Saboda babban rauni, zubar jini da rikitarwa na tiyata, babu asibitoci da yawa da ke gudanar da bincike na asibiti.

A cikin 'yan shekarun nan, aikace-aikace na thrombolytic kwayoyi da kuma saurin ci gaba da fasahar intravascular ya sa ra'ayi na "ƙwaƙwalwar thrombus" ya kasance.Dangane da maganin rigakafin jijiyoyi, ana iya ɗaukar maganin thrombolytic azaman zaɓin dabarun aiki da inganci, wanda ya dace da marasa lafiya na DVT waɗanda ke ware contraindications na thrombolytic.

A halin yanzu, urokinase (UK) da alteplase sune abubuwan da aka fi amfani da su na fibrinolytic a cikin DVT na maganin thrombolytic na asibiti a gida da waje.Thrombolytic far zai iya hanzarta thrombolytic recanalization, kare aikin bawul, rage abin da ya faru na PTS, da kuma inganta rayuwar marasa lafiya da gaskiya da alaka da mataki na thrombolysis.Za a iya raba maganin thrombolytic zuwa thrombolysis na gefe (tsarin thrombolysis) da catheter directed thrombolysis (CDT).

Tare da haɓaka kayan aiki da fasaha, CDT yana da fa'idodi masu mahimmanci a cikin kula da DVT.Yana tuntuɓar thrombus na gida kai tsaye tare da magungunan thrombolytic, wanda ke haɓaka haɓakar magungunan thrombolytic a kusa da thrombus.Yankin hulɗar tsakanin magungunan thrombolytic da thrombus ya fi girma fiye da na jijiyar jijiyoyi.Jiyya na CDT yana ƙara yawan adadin magungunan da ke aiki akan thrombus, yana ƙaruwa da haɓakar haɓakar jijiyoyin jini bayan thrombolysis, kuma tasirin warkewa ya fi na thrombolysis na gefe.

CDT ya zama hanyar thrombolytic da aka fi amfani dashi a halin yanzu, wanda zai iya rage rikice-rikicen jini yadda ya kamata yayin haɓaka thrombolysis.Pharmaceutical mechanical thrombectomy (PMCT) wata na'ura ce mai jujjuyawa a karshen kai, wanda zai iya shred thrombus kuma ya tsotse shi a cikin catheter ta hanyar matsi mara kyau, sannan a hada shi da CDT na gargajiya, wanda zai iya rage adadin magungunan thrombolytic da lokacin jiyya kusan kusan. 50%.

Tasirin cirewar thrombus na PMCT da CDT iri ɗaya ne, amma PMCT ya fi aminci, yana haɓaka thrombus recanalization, yana rage lokacin jiyya, yana rage aikace-aikacen magungunan thrombolytic da rikicewar jini, yana rage haɗarin PTS, yana rage adadin kwanaki a asibiti kuma yana raguwa. kudin asibiti.

Nazarin Cavent nazari ne da bazuwar tsarin kula da daidaitaccen maganin maganin jijiyoyi da aka haɗa tare da CDT da daidaitaccen maganin maganin jijiyoyi akan thrombosis mai zurfi na iliofemoral, wanda ya ɗauki marasa lafiya daga asibitoci 20 a Arewa maso Yamma Norway.

Sakamakon wannan binciken ya nuna cewa idan aka kwatanta da maganin ƙwanƙwasa jini kawai, haɗin CDT na iya rage haɗarin PTS sosai, amma dan kadan yana ƙara haɗarin zubar jini.Duk da haka, idan aka kwatanta da tsarin thrombolysis, wannan haɗarin zubar da jini yana da alama abin karɓa.

Wannan sakamakon yana goyan bayan shawarwarin jagororin kwanan nan waɗanda za a iya yin la'akari da haɗin gwiwar jiyya na CDT a cikin marasa lafiya tare da thrombosis mai zurfi mai zurfi da ƙananan haɗarin jini.

Bayanin kamfani

Thekamfaniyana da nasamasana'antada kuma ƙungiyar ƙira, kuma an daɗe a cikin samarwa da siyar da samfuran likitanci.Yanzu muna da layin samfuran masu zuwa.

kwat din matsawa iska(kafar matsawa iska,takalman matsawa,tufafin matsawa iska da na kafadada sauransu) kumaFarashin DVT.

Rigar tsarin share fage

Yawon shakatawacuff

④ Zafi da sanyiPads na magani(fakitin kankara, gwiwar hannu kankara, fakitin kankara don gwiwa, hannun riga mai sanyi, fakitin sanyi don kafada da sauransu)

⑤ Wasu kamar samfuran jama'a na TPU (inflatable pool,anti-gado da katifa mai kumburi,sanyi maganin gwiwa injiect)


Lokacin aikawa: Satumba-30-2022